Abstract. Altered expression of caveolin-1 (Cav-1) is observed in various types of cancers. However, little research has been reported regarding the correlation between the expression of Cav-1 and cervical cancer. Here, we investigated the clinical significance of Cav-1 expression using quantum dot (QD)-based immunofluorescence staining in cervical cancer and its correlation with high-risk human papilloma virus (HPV) infection detected by chromogenic in situ hybridization. Our results showed that the positive rates of Cav-1 protein in normal cervical mucosa, CIN, cervical adenocarcinoma and SCC were: 0, 33, 19 and 55%, respectively. The differences in Cav-1 protein expression in cervical SCC compared to the other three groups were all statistically significant. Absence of stromal Cav-1 protein in 58 cases of cervical SCC was 67%. The positive rates of the Cav-1 protein in tumour and stromal cells of cervical SCC were not correlated with clinicopathological parameters. In the cervical SCC tissues, Cav-1 expression in tumour cells was not associated with stromal Cav-1 expression, but a positive correlation existed with the PCNA protein and high-risk of HPV infection. The results presented here suggest that expression of Cav-1 in the tumour cells, rather than in the stromal tissue surrounding the tumour, may promote cervical SCC cell proliferation, and correlates with high-risk HPV infection.
IntroductionCervical cancer is one of the most common cancer among women worldwide, and its incidence is higher in people of low socioeconomic status in developing countries, including China. It is well known that cervical carcinogenesis is caused by persistent oncogenic high-risk human papillomavirus (HR-HPV) infection (1,2). However, not all of the infected women will develop cervical cancer, still other genetic and epigenetic factors including tumour suppressor gene, oncogene, cell cycle regulating factors and apoptosis, may be involved in tumour progression (1).The caveolin (Cav) family includes Cav-1, Cav-2 and Cav-3. Cav-1 is the major structural protein of caveolae and functionally regulates the activity of many signaling molecules, which are potentially involved in the development of human cancer. Cav-1 is widely expressed in fully differentiated or quiescent cells, such as adipocytes, fibroblasts, alveolar epithelial cells, endothelial cells and smooth muscle cells. Previous studies of Cav-1 in various types of cancer showed two contrary results. On one hand, expression of Cav-1 is increased in cancer of the prostate (3), pancreas (4), breast (5), colon (6), tongue (7) and esophagus (8), thus, indicating that it plays a positive role in tumour progression. On the other hand, expression of Cav-1 is decreased in the lung (9), colon (10), ovary (11), breast (12,13), stomach (14) and thyroid cancer (15). Cav-1 has a different expression pattern across tissues in different organs, despite such tissues having the same histological type, such as squamous cell carcinomas. These data imply that Cav-1 may have multiple activiti...